Ovide Lotion
NDC Package 51672-5293-4

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Ovide (malathion) lotions is a medication used to treat head lice, tiny insects that infest and irritate your scalp. This formulation utilizes a lotion delivery system. Marketed by Taro Pharmaceuticals U.s.a., Inc., this product is identified by NDC 51672-5293 and is authorized under FDA application ANDA091559.

Identification & Billing

NDC Package Code
51672-5293-4
Package Description
1 BOTTLE in 1 CARTON / 59 mL in 1 BOTTLE
Product Code
51672-5293
11-Digit Billing Format
51672529304
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Ovide
Non-Proprietary Name
Malathion
Substance Name
Malathion
Dosage Form
Lotion - An emulsion, liquid1 dosage form. This dosage form is generally for external application to the skin.2
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
MALATHION .0005 g/mL
Pharmacologic Class
Usage Information
This medication is used to treat head lice, tiny insects that infest and irritate your scalp. Malathion belongs to a class of drugs known as organophosphates. It works by paralyzing and killing lice and their eggs (nits).

Regulatory & Marketing

Labeler Name
Taro Pharmaceuticals U.s.a., Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA091559
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-31-2014
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51672-5293-4 identifies a specific commercial package of 1 bottle in 1 carton / 59 ml in 1 bottle of Ovide, a human prescription drug labeled by Taro Pharmaceuticals U.s.a., Inc.. This lotion is formulated for topical use and contains malathion as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Taro Pharmaceuticals U.s.a., Inc. on January 31, 2014. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat head lice, tiny insects that infest and irritate your scalp. Malathion belongs to a class of drugs known as organophosphates. It works by paralyzing and killing lice and their eggs (nits).

How is this Taro Pharmaceuticals U.s.a., Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51672529304. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51672-5293-4
11-Digit CMS (5-4-2)
51672-5293-04

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.